286 related articles for article (PubMed ID: 22697792)
1. Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression.
Knutson TP; Daniel AR; Fan D; Silverstein KA; Covington KR; Fuqua SA; Lange CA
Breast Cancer Res; 2012 Jun; 14(3):R95. PubMed ID: 22697792
[TBL] [Abstract][Full Text] [Related]
2. Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs.
Knutson TP; Truong TH; Ma S; Brady NJ; Sullivan ME; Raj G; Schwertfeger KL; Lange CA
J Hematol Oncol; 2017 Apr; 10(1):89. PubMed ID: 28412963
[TBL] [Abstract][Full Text] [Related]
3. Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells.
Daniel AR; Lange CA
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14287-92. PubMed ID: 19706513
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells.
Daniel AR; Faivre EJ; Lange CA
Mol Endocrinol; 2007 Dec; 21(12):2890-906. PubMed ID: 17717077
[TBL] [Abstract][Full Text] [Related]
5. Control of progesterone receptor transcriptional synergy by SUMOylation and deSUMOylation.
Abdel-Hafiz HA; Horwitz KB
BMC Mol Biol; 2012 Mar; 13():10. PubMed ID: 22439847
[TBL] [Abstract][Full Text] [Related]
6. ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells.
Hagan CR; Regan TM; Dressing GE; Lange CA
Mol Cell Biol; 2011 Jun; 31(12):2439-52. PubMed ID: 21518957
[TBL] [Abstract][Full Text] [Related]
7. Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells.
Labriola L; Salatino M; Proietti CJ; Pecci A; Coso OA; Kornblihtt AR; Charreau EH; Elizalde PV
Mol Cell Biol; 2003 Feb; 23(3):1095-111. PubMed ID: 12529413
[TBL] [Abstract][Full Text] [Related]
8. Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors.
Faivre EJ; Daniel AR; Hillard CJ; Lange CA
Mol Endocrinol; 2008 Apr; 22(4):823-37. PubMed ID: 18202149
[TBL] [Abstract][Full Text] [Related]
9. Progesterone receptor-cyclin D1 complexes induce cell cycle-dependent transcriptional programs in breast cancer cells.
Dressing GE; Knutson TP; Schiewer MJ; Daniel AR; Hagan CR; Diep CH; Knudsen KE; Lange CA
Mol Endocrinol; 2014 Apr; 28(4):442-57. PubMed ID: 24606123
[TBL] [Abstract][Full Text] [Related]
10. Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases.
Skildum A; Faivre E; Lange CA
Mol Endocrinol; 2005 Feb; 19(2):327-39. PubMed ID: 15486045
[TBL] [Abstract][Full Text] [Related]
11. Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth.
Daniel AR; Qiu M; Faivre EJ; Ostrander JH; Skildum A; Lange CA
Steroids; 2007 Feb; 72(2):188-201. PubMed ID: 17173941
[TBL] [Abstract][Full Text] [Related]
12. Tracking progesterone receptor-mediated actions in breast cancer.
Knutson TP; Lange CA
Pharmacol Ther; 2014 Apr; 142(1):114-25. PubMed ID: 24291072
[TBL] [Abstract][Full Text] [Related]
13. Estrogen-related receptor alpha1 transcriptional activities are regulated in part via the ErbB2/HER2 signaling pathway.
Ariazi EA; Kraus RJ; Farrell ML; Jordan VC; Mertz JE
Mol Cancer Res; 2007 Jan; 5(1):71-85. PubMed ID: 17259347
[TBL] [Abstract][Full Text] [Related]
14. Mitogen-activated protein kinase regulates nuclear association of human progesterone receptors.
Qiu M; Olsen A; Faivre E; Horwitz KB; Lange CA
Mol Endocrinol; 2003 Apr; 17(4):628-42. PubMed ID: 12554776
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylated Progesterone Receptor Isoforms Mediate Opposing Stem Cell and Proliferative Breast Cancer Cell Fates.
Truong TH; Dwyer AR; Diep CH; Hu H; Hagen KM; Lange CA
Endocrinology; 2019 Feb; 160(2):430-446. PubMed ID: 30597041
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms underlying the control of progesterone receptor transcriptional activity by SUMOylation.
Abdel-Hafiz H; Dudevoir ML; Horwitz KB
J Biol Chem; 2009 Apr; 284(14):9099-108. PubMed ID: 19211567
[TBL] [Abstract][Full Text] [Related]
17. TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.
Gizard F; Robillard R; Gross B; Barbier O; RĂ©villion F; Peyrat JP; Torpier G; Hum DW; Staels B
Mol Cell Biol; 2006 Oct; 26(20):7632-44. PubMed ID: 17015480
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of Telapristone Acetate (CDB4124) on Progesterone Receptor Action in Breast Cancer Cells.
Davaadelger B; Murphy AR; Clare SE; Lee O; Khan SA; Kim JJ
Endocrinology; 2018 Oct; 159(10):3581-3595. PubMed ID: 30203004
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2.
Pierson-Mullany LK; Lange CA
Mol Cell Biol; 2004 Dec; 24(24):10542-57. PubMed ID: 15572662
[TBL] [Abstract][Full Text] [Related]
20. Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators.
Faivre E; Skildum A; Pierson-Mullany L; Lange CA
Steroids; 2005; 70(5-7):418-26. PubMed ID: 15862825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]